BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laryngoscope
,
Lipitor
,
rs7903146
,
FABP1
,
Response to oxidative stress
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
miglustat
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
UGCG
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
dihydroceramide glucosyltransferase activity
Ceramide glucosyltransferase
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN
MODULE_346
MODULE_236
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy and safety of miglustat in the treatment of GM2 gangliosidosis: A systematic review.
N-butyldeoxynojirimycin (miglustat) ameliorates pulmonary fibrosis through inhibition of nuclear tra…
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe …
Comparing the efficacy of cipaglucosidase alfa plus miglustat with other enzyme replacement therapie…
Probable Miglustat-Induced Psychosis in a Child With Niemann-Pick Type C.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Miglustat on Gaucher Disease Type IIIB
Miglustat in Cystic Fibrosis
Testing Miglustat Administration in Subjects With Spastic Paraplegia 11
Application of Miglustat in Patients With Niemann-Pick Type C
Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ